GLP-1 meds (Ozempic etc.), the PCOS game-changer?

Polycystic Ovary Syndrome (PCOS) remains one of the most common yet complex conditions affecting women’s health, with limited treatment options and persistent challenges in care.

This webinar brings together leading experts to review the current landscape of PCOS management, highlight emerging research, and introduce GLP-1 as a promising new approach.

Attendees will gain insights into the latest clinical findings, practical considerations for patient care, and the potential impact of GLP-1 therapies on fertility and reproductive outcomes.

The session will conclude with a live Q&A, offering participants the chance to engage directly with our speakers.

In the meantime, if you’re experiencing symptoms and want to get to the bottom of them, personalise your test which screens for up to 18 conditions, including PCOS.

Hertility is the leading healthcare provider for women, developing next-generation technology to empower people to understand and care for their bodies better, smarter and faster than ever before.

Launched in 2021, powered by leading doctors, the Advanced At-Home Hormone and Fertility test provides advanced insights into reproductive health, fertility decline and the onset of menopause as well as screening for up to 18 conditions that affect reproductive health (such as PCOS) in just 10 days. And our comprehensive onward services empower women to choose care on their terms, with industry-leading in-house experts and trusted partner clinics.

With over half a million users (and counting), Hertility is building the largest and most comprehensive real-world dataset of modern women today, deciphering billions of under-researched data points to put an end to women’s bodies being ‘too complex’ and work towards a world where all women have the clarity they deserve.

Founded by scientists Dr Helen O’Neill and Dr Natalie Getreu with corporate lawyer Deirdre O’Neill, the Hertility team includes researchers, data engineers, entrepreneurs and clinicians with over 100 years combined clinical experience at organisations like Imperial College London NHS Trust, Queen Charlotte’s & Chelsea, St Mary’s Hospitals and more.